John M. Haynes

PEGylation does not significantly change the initial intravenous or subcutaneous pharmacokinetics or lymphatic exposure of trastuzumab in rats but increases plasma clearance after subcutaneous administration.

D. Ascher, Victoria M Mcleod, C. Porter, 2015, Molecular pharmaceutics.